Austria · Delayed Price · Currency is EUR FACC AG Earnings Call Transcripts
Fiscal Year 2025
-
Revenue grew 11.3% to €984.4M and EBIT rose 49.4% amid strong demand and efficiency gains. All divisions contributed positively, free cash flow surged, and a €350M investment plan is underway. Dividend payments resume with €0.10 per share.
-
Revenue grew 8.6% year-over-year to EUR 697.6 million, with strong free cash flow and improved efficiency. Full-year 2025 guidance targets EUR 1 billion in revenue and a 4-5% EBIT margin, supported by robust demand and ongoing cost-saving initiatives.
-
Revenue rose 10.6% to EUR 484.7 million, with all divisions posting positive EBIT despite supply chain and material cost challenges. Order backlog hit a record EUR 6 billion, and full-year revenue is expected to exceed EUR 1 billion, with margin improvement targeted.
-
Q1 2025 saw 14% revenue growth and a return to positive free cash flow, despite EBIT margin pressure from supply chain and material costs. Guidance for 5-15% annual growth is maintained, with strong demand and efficiency initiatives supporting future performance.
Fiscal Year 2024
-
Revenue grew 20% to EUR 884.5 million in 2024, with EBIT up 62% and a strong order backlog supporting future growth. Management targets 5%-15% revenue growth in 2025, continued margin improvement, and major cost savings through the CORE initiative. Advanced air mobility and efficiency projects are key strategic focuses.
-
Revenue grew 25% year-over-year to EUR 642.6 million, with strong order backlog and ongoing ramp-ups across all major programs. EBIT improved but free cash flow remains negative due to inventory buildup, prompting a transformation plan targeting EUR 50 million in inventory reduction by 2025. EBIT margin for the year is guided at 3%-4% with further productivity gains expected.
-
Sales grew 24% year-over-year in H1 2024, with EBIT up over 50% and strong order backlog. Inventory reduction and efficiency remain key priorities, while full-year guidance of 10%-15% growth is confirmed despite expected Q3 seasonality.